Intellectual Property India Publishes Patent Application for 'Inhibitors Of KIF18A And Uses Thereof' Filed by Accent Therapeutics Inc.

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517020135 A) filed by Accent Therapeutics Inc., Lexington, U.S.A., on March 6, for 'inhibitors of kif18a and uses thereof.'

Inventor(s) include Sparling Brian Andrew; Duncan Kenneth W.; Zablocki Mary Margaret; Daniels Matthew H.; Ericsson Anna; Tasker Andrew Stewart; and Lee Matthew R.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "Provided are compounds of the Formula (I): or pharmaceutically acceptable salts thereof which are useful for the inhibition of KIF18A and in the treatment of a variety of KIF18A mediated conditions or diseases such ...